• Melanie Buser, PhD, DABT, MPH; RHP Risk Management
• Greg Sperla, Esq., DLA Piper
• Additional Speaker Coming Soon

Topics for Discussion:

• Distinguish chemical listing, analytical detection, real-world exposure, and the ultimate warning decision.
• Evaluate how chemical identity, speciation, release, foreseeable use, exposure route, and frequency affect the meaning of laboratory results.
• Understand how safe harbor levels and product-specific risk analyses inform 60-day notices, compliance decisions, and litigation strategy.
• Apply these principles through a vinyl acetate case study, including OEHHA’s information letter and September 2026 pre-rulemaking proposal.

For more information, contact Allison Gill, agill@perrinconferences.com.